piwik-script

Deutsch
    Chair of Biochemistry

    Renteln, Michael

    Michael Renteln   

    Group: Molecular Oncology
    Phone: +49 931 - 31 82665
    E-mail: michael.renteln@uni-wuerzburg.de
    Room: B117

     

     

     

     

     

     

     


    Curriculum vitae

    Name

    Michael Renteln

     

    Position

    Research Assistant

    Affiliation

     

    Chair of Biochemistry, Theodor-Boveri-Institute at the Biocentre
    AG Szalay
    University of Würzburg
    Am Hubland
    97074 Würzburg, Germany
    Phone +49 931 - 31 82665

     

    michael.renteln@uni-wuerzburg.de

    Career

    5/2013
    5/2014

    B.S. in Biochemistry, University of Southern California USC, Los Angeles, CA, U.S.A.
    M. Sc. in Molecular Genetics and Biochemistry

     

    7/2010 - 06/2012

    Research Assistant
    Dr. Caleb Finch's Lab: The Neurobiology of Aging
    USC, Los Angeles, U.S.A.

     

    6/2012 - 5/2014

    Research Assistant
    Dr. Valter Longo's Lab: Mechanisms of Aging
    USC, Los Angeles, U.S.A.

     

    8/2015 - 10/2018

    Various Lab Rotations
    Baylor College of Medicine, Houston, Texas, U.S.A.

     

    5/2019 - 6/2021

    Dr. Howard Xu's Lab: Combatting Antibiotic Resistance
    Cal State LA, Los Angeles, U.S.A.

      6/2020 - 6/2021

    Dr. Michael Jakowec's Lab: Molecular Mechanisms of Neuroplasticity
    USC, LA, U.S.A.

    ­

    Research Fields

    Oncolytic viruses, vaccination, longevity research

     


    Publications

    Selected Publications

    1. Davis DA, Akopian G, Walsh JP, Renteln MA, Ning Z, Sioutas C, Morgan TE, Finch CE. Air pollution alters glutamate receptor function. Society for Neuroscience 2011 Meeting, Abstract Control
    #11556 (https://www.abstractsonline.com/Plan/ViewAbstract.aspx?mID=2773&sKey=89896939-f7e0-446e-8d66-36760e8d7c43&cKey=2f7d1045-5287-4d3a-b0c2-a4723dcc1edc&mKey=8334be29-8911-4991-8c31-32b32dd5e6c8)


    2. Renteln M. Conditional replication of oncolytic viruses based on detection of oncogenic mRNA.Gene Therapy 2018; 25: 1–3. (https://www.nature.com/articles/gt201799)


    3. Renteln M. A synthetic mitochondrial-based vector for therapeutic purposes. Medical Hypotheses 2018; 0. doi:10.1016/j.mehy.2018.05.014.(https://www.sciencedirect.com/science/article/abs/pii/S030698771830375X?via%3Dihub)